We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Robin Djang MD

Robin Djang MD

Fellow, Urologic Oncology, University of Oklahoma Health Sciences Center & The Stephenson Cancer Center, Oklahoma City, Oklahoma

Dr. Robin Djang is a fellow in urologic oncology at the University of Oklahoma Health Sciences Center.  He graduated from Boston University School of Medicine and completed his urology residency at Dartmouth-Hitchcock Medical Center in Lebanon, New Hampshire.  He is a member of the Society of Urologic Oncology (SUO) and American Urological Association (AUA).  His research interests include the application of novel technologies to optimize outcomes in patients with bladder and prostate cancer and developing new surgical approaches for enhanced recovery after bladder cancer treatment.   


No disclosures reported.